Patients' understanding and participation in a trial designed to improve the management of anti-psychotic medication - A qualitative study

Social Psychiatry and Psychiatric Epidemiology

Volumn 38, Issue 12, 2003, Pages 720-727

  Rogers, Anne ^a   Day, Jenny ^b   Randall, Fiona ^a   Bentall, Richard P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Anti psychotic medication; Patient perspectives; Qualitative; Randomised controlled trials

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERVIEW; MALE; MENTAL DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; MENTAL HEALTH THERAPIES;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT CARE TEAM; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; PSYCHOTIC DISORDERS;

EID: 1842435161     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-003-0693-5     Document Type: Article

References (27)

1. Applebaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Center Report April 20-24
2. Blaxter M, Britten N (1996) Lay beliefs about drugs and medicines and the implications for community pharmacy. Pharmacy Practice Research and Resource Centre, Manchester
3. Boczkowski JA, Zeichner A, Desanto N (1985) Neuroleptic compliance among chronic schizophrenic outpatients. J Consult Clin Psychol 53:666-671
4. Campbell M, Fitzpatrick R, Haines A, Kinmouth A, Sandercock P, Spiegelhalter, Tyrer P (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321: 694-696
5. Corrigan PW, Liberman RP, Engel JD (1990) From non-compliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 41:1203-1211
6. Davidhizare RE (1985) Can clients with schizophrenia describe feelings and beliefs about taking medication? J Adv Nursing 10: 469-472
7. Day J, Bentall RP (1996) Schizophrenic patients' experience of neuroleptic medication: a q-methodological investigation. Acta Psychiatr Scand 93:397-402
8. Donovan JL, Blake DR (1992) Patient non-compliance - deviance or reasoned decision making? Soc Sci Med 34(5):507-513
9. Eckman TA, Liberman RP (1990) A large-scale field test of a medication management skills training program for people with schizophrenia. Psychosoc Rehabili J 13:31-35
10. Edwards SJL, Lilford RJ, Thornton J, Hewison J (1998) Informed Consent for clinical trials: in search of the 'best' method. Soc Sci Med 47(11):1825-1840
11. Featherstone K, Donovan J (2002) "Why don' t they just tell me straight. Why allocate it?" The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med 55(5): 709-719
12. Featherstone K (2001) "Why don't they just tell me straight. Why allocate it"? The struggle to make sense of participating in a randomised controlled trial. Presentation given to the BSA Medical Sociology Group Conference 21st-23rd September 2001, York University
13. Greene J (1994) Qualitative programme evaluation: practice and promise. In: Denzin N, Lincoln Y (eds) Handbook of Qualitative Research. Sage, London
14. Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical anti-psychotics in the treatment of schizophrenia. BMJ 321: 1371-1376
15. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13:177-183
16. Kelly GR, Scott JE (1990) Medication compliance and health education among chronic outpatients with mental disorders. Medical Care 28:1181-1197
17. Kemp R, Hayward P, Applewhaite G etal. (1996) Compliance therapy in psychotic patients: randomised controlled trial. BMJ 312:345-349
18. Kemp R, Kirov G, Everitt B, Hayward P, David A (1998) Randomised controlled trial of compliance therapy. Br J Psychiatry 172:413-419
19. Macpherson R, Jerrom B, Hughes A (1996) A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 168:709-717
20. Mason S, Tovey P, Long A (2002) Evaluating complementary medicine: methodological outcome challenges of randomised controlled trials. BMJ 325:832-834
21. Noblit GW (1988) Meta ethnography: synthesising qualitative studies. Sage, Newbury Park California
22. Pawson R, Tilley N (1998) Realistic evaluation. Sage, London
23. Ramon S, Castillo H, Morant N (2001) Experiencing personality disorder: a participative research. Intern J Soc Psychiatry 47(4): 1-15 Win 2001
24. Randall F, Wood P, Day J, Bentall R, Rogers A, Healy D (2002) Enhancing appropriate adherence with neuroleptic medication. Two contrasting approaches. In: Morrison AP (ed) A casebook of cognitive therapy for psychosis. Brunner-Routledge, Hove, pp 81-297
25. Royal Pharmaceutical Society of Great Britain (1997) From compliance to concordance: towards shared goals in medicine taking. RPSGB, London
26. Rogers A, Day J, Williams B, Randall F, Wood P, Healy D, Bentall RP (1998) The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Soc Sci Med 47:1313-1323
27. Thornicroft G, Rose D, Huxley P, Dale G, Wykes T (2002) What are the research priorities of mental health service users. J Ment Health 11:1-5